Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGC20-0582 for Head Lice Infestation
NCT00528021Phase 2Completed
- Sponsor
- Boston Scientific Corporation
- Start
- Aug 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BGC20-0582 in pediculosis capitis (4 arms), sponsored by Boston Scientific Corporation. Primary endpoint: Clinical Cure at Day 22. Started Aug 2007; status: completed.
02
Drugs
BGC20-0582
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT00528021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528021.